Literature DB >> 19103852

Starting neonatal screening for haemoglobinopathies in The Netherlands.

P C Giordano1.   

Abstract

Neonatal screening for haemoglobinopathies started in The Netherlands on 1 January 2007. The method of choice, high-performance liquid chromatography, and the universal setting have shown that the predicted incidence is indeed present in the country. Patients and carriers are reported in order to prevent morbidity, and for the primary prevention of serious haemoglobinopathies. Background, preceding discussion, health gain, implementation, provisional results and ethics issues are discussed, as well as matters concerning technology, know-how, and ongoing and future developments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19103852     DOI: 10.1136/jcp.2008.058826

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

2.  Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.

Authors:  Elisa Ballardini; Anna Tarocco; Maria Marsella; Roberto Bernardoni; Gianni Carandina; Claudia Melandri; Giovanni Guerra; Alfredo Patella; Miranda Zucchelli; Alessandra Ferlini; Stefania Bigoni; Anna Ravani; Giampaolo Garani; Caterina Borgna-Pignatti
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

3.  Screening and genetic diagnosis of hemoglobinopathies in southern and northern europe: two examples.

Authors:  Antonio Amato; Piero C Giordano
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-08-08       Impact factor: 2.576

4.  A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.

Authors:  Suze M P J Jans; Carla G van El; Eddy S Houwaart; Marjan J Westerman; Rien J P A Janssens; Antoinette L M Lagro-Janssen; Anne Marie C Plass; Martina C Cornel
Journal:  Ethn Health       Date:  2011-08-08       Impact factor: 2.772

5.  Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.

Authors:  Stephanie S Weinreich; Elly Sm de Lange-de Klerk; Frank Rijmen; Martina C Cornel; Marja de Kinderen; Anne Marie C Plass
Journal:  BMC Public Health       Date:  2009-09-15       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.